Futura Medical plc (AIM: FUM)

Market Cap	97.03M
Revenue (ttm)	8.40M
Net Income (ttm)	-3.75M
Shares Out	303.70M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	211.59
Dividend	n/a
Ex-Dividend Date	n/a

Volume	395,711
Open	33.15
Previous Close	32.75
Day's Range	31.72 - 33.15
52-Week Range	21.50 - 47.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 11, 2024

About Futura Medical

Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health. Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 12
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: FUM